In this article, we’ll compare semaglutide, liraglutide, and tirzepatide, specifically looking at their efficacy, dosage, ...

Nanexa AB announces that initial observations in the phase I study show that the 30 mg dose of NEX-22, a depot formulation of liraglutide, has been well tolerated by patients with type 2 diabetes who ...